Dose escalated neoadjuvant chemoradiotherapy with dose-painting intensity-modulated radiation therapy and improved pathologic complete response in locally advanced esophageal cancer

Overview

cited authors

Venkat, P. S.; Shridhar, R.; Naghavi, A. O.; Hoffe, S. E.; Almhanna, K.; Pimiento, J. M.; Fontaine, J-P.; Abuodeh, Y.; Meredith, K. L.; Frakes, J. M.

authors

Shridhar, Ravi, MD

Publication Date

July 1, 2017

webpage

Web of Science

published in

DISEASES OF THE ESOPHAGUS Journal

Research

keywords

IGRT
IMRT
PCR
combined modality therapy
esophageal carcinoma
neoadjuvant chemoradiation

301 E Princeton St., Orlando, FL 32804 | FH.RAS@AdventHealth.com | 407-200-2901

The information on this website is not a substitute for examination, diagnosis, and medical care provided by a licensed and qualified health professional. Please consult your physician before undertaking any form of medical treatment and/or adopting any exercise program or dietary guidelines. If you think you may have a medical emergency, call your physician or 911 immediately. AdventHealth Research Institute reserves the right to add, remove or edit content on this page at its sole discretion.